Skip to content
This GLP
By This GLP Editorial Team · Updated September 2026Locked as you titrate

Somira Health review

The price is stated as locked while the dose rises, on both plan lengths.

The verdict

Somira Health publishes $139.99 a month for compounded semaglutide and $159.99 for tirzepatide. Each renews at the same figure every month. The price is stated as locked during titration.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
From $139.99/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Somira Health sells both molecules by injection. Two billing options exist. The quarterly plan is billed as a single total.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages state plans and totals. The clinician is not described.

    The titration guarantee is the claim to hold them to. It applies to both plan lengths and it is stated rather than implied.

  2. What happens when the dose goes up?

    Price locked as you titrate is the seller's own wording. That answers the dose question directly. Nothing describes clinical support at a step.

  3. What the price includes

    Six months month to month is $839.94 on semaglutide and $959.94 on tirzepatide. A quarterly plan bills in one charge at a lower monthly equivalent. The configurator shows its total before checkout.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: Price stated as locked during titration
  • Strength: Quarterly totals published, not just rates
  • Strength: The pharmacy is named on the plan card
  • Limitation: The quarterly plan bills in one charge
  • Limitation: No milligram dose published
  • Limitation: No state coverage list is recorded

What the evidence says about this kind of treatment

The assessment above is about Somira Health. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who wants the rate pinned across an escalation.
Wrong for
A reader who needs a monthly charge rather than a quarterly one.

The evidence behind what Somira Health prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How Somira Health compares

SellerWho it suitsGo
SunlightReaders who want a rate guaranteed against increases and will count the fillsSee Sunlight →
SurpassMDReaders who will ask what their own approved figure isSee SurpassMD →
TeleCareSpotReaders confident of approval who want a flat all-in rateSee TeleCareSpot →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: WeightRxWeightWatchers ClinicWelling HealthWellspring Longevity ClinicWePeptideRxWholesome Clinic

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Does the price rise with the dose?
No. The seller states the price is locked as you titrate.
What does the quarterly plan cost?
It bills once a quarter, below the monthly rate. The configurator shows the total before checkout.
What does tirzepatide cost?
$159.99 a month, renewing at the same figure each month.
Is Somira Health expensive compared with other GLP-1 telehealth sellers?
Somira Health publishes a starting figure of $139.99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Somira Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
This GLP Editorial TeamPublisher · Updated September 2026

How this was assessed. The four questions above are answered from Somira Health’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.